NOXA Protein

📖 Wiki Page

protein1296 wordssynced 2026-04-02

NOXA Protein

<div class="infobox infobox-protein">
<div class="infobox-header">NOXA Protein (PMAIP1)</div>
<div class="infobox-row"><span class="infobox-label">Protein Name</span><span class="infobox-value">Phorbol-12-Myristate-13-Acetate-Induced Protein 1 (NOXA)</span></div>
<div class="infobox-row"><span class="infobox-label">Gene</span><span class="infobox-value">[PMAIP1](/genes/noxa)</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[Q13794](https://www.uniprot.org/uniprot/Q13794)</span></div>
<div class="infobox-row"><span class="infobox-label">Molecular Weight</span><span class="infobox-value">~6.5 kDa (54 aa)</span></div>
<div class="infobox-row"><span class="infobox-label">Subcellular Localization</span><span class="infobox-value">Mitochondrial outer membrane, Cytoplasm</span></div>
<div class="infobox-row"><span class="infobox-label">Protein Family</span><span class="infobox-value">BCL-2 family, BH3-only subgroup</span></div>
<div class="infobox-row"><span class="infobox-label">Associated Diseases</span><span class="infobox-value">Neuronal apoptosis in AD, PD, stroke, and excitotoxicity</span></div>
</div>

Overview

...

NOXA Protein

Overview

NOXA (also known as PMAIP1, Phorbol-12-Myristate-13-Acetate-Induced Protein 1) is a BH3-only pro-apoptotic member of the [BCL-2 protein family](/mechanisms/bcl2-family-apoptosis) that functions as a critical effector of [p53](/proteins/p53-protein)-dependent and stress-induced [apoptosis](/entities/apoptosis). NOXA is a small 54-amino-acid protein encoded by the PMAIP1 gene on chromosome 18q21.32. Its name derives from the Latin word for "damage," reflecting its role as a damage-responsive cell death promoter.[@oda2000] NOXA selectively neutralizes the anti-apoptotic protein [MCL-1](/proteins/mcl1-protein), displacing pro-apoptotic effectors [BAK](/proteins/bak-protein) and [BAX](/proteins/bax-protein) to trigger mitochondrial outer membrane permeabilization (MOMP), cytochrome c release, and caspase activation.[@chen2005] In the nervous system, NOXA is upregulated during ischemia, excitotoxicity, DNA damage, and proteasome inhibition, contributing to neuronal death in multiple neurodegenerative conditions including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).[@bhatt2007]

Structure and Biochemistry

NOXA is one of the smallest members of the BCL-2 family. It lacks the globular multi-BH-domain architecture of pro-survival proteins (BCL-2, BCL-XL, MCL-1) and the multi-domain pro-apoptotic effectors (BAX, BAK). Instead, NOXA is intrinsically disordered except when bound to a partner, and its function is entirely mediated by three key structural elements:

BH3 domain (residues 21–36) — the essential amphipathic alpha-helix that inserts into the hydrophobic groove of anti-apoptotic BCL-2 proteins. NOXA's BH3 domain has an unusual binding selectivity: it binds MCL-1 and A1 (BFL-1) with nanomolar affinity but has negligible binding to BCL-2, BCL-XL, or BCL-W.[@chen2005] This selectivity is determined by four key residues (L29, R31, D34, E35) that form complementary contacts with MCL-1's binding groove.[@day2008]
C-terminal mitochondrial targeting region (MTR, residues 40–54) — directs NOXA to the mitochondrial outer membrane, positioning it to interact with MCL-1 at the site where MOMP occurs.[@seo2009]
N-terminal regulatory region (residues 1–20) — contains phosphorylation sites (Ser13) and ubiquitination sites that regulate NOXA stability and turnover.

NOXA has an extremely short half-life (~30 minutes) in unstressed cells, maintained by constitutive ubiquitin-proteasome degradation. This ensures that NOXA is only functionally active during acute stress when its transcription is strongly induced.[@seo2009]

Normal Function in the Nervous System

p53-Dependent DNA Damage Response

NOXA was originally identified as a p53-target gene induced by ionizing radiation.[@oda2000] In post-mitotic [neurons](/entities/neurons), which cannot undergo cell cycle arrest as a DNA damage response, p53 activation by genotoxic stress preferentially engages the apoptotic program rather than senescence. NOXA transcription is directly activated by p53 binding to two response elements in the PMAIP1 promoter.[@oda2000] This positions NOXA as a key effector of DNA damage-induced neuronal death.

Cellular Stress Sentinel

Beyond p53, NOXA is transcriptionally induced by multiple stress-responsive transcription factors relevant to neurodegeneration:

HIF-1alpha — induced by hypoxia, activates NOXA during ischemic conditions[@kim2004]
E2F1 — deregulated cell cycle re-entry in neurons (a feature of AD pathology) activates E2F1-dependent NOXA transcription
ATF3/ATF4 — endoplasmic reticulum stress through the [unfolded protein response](/entities/unfolded-protein-response) (UPR) pathway PERK-eIF2alpha-ATF4 induces NOXA expression[@wang2009]
FOXO3a — oxidative stress activates FOXO3a, which directly transactivates the PMAIP1 promoter in neurons

MCL-1 Regulation and Apoptotic Threshold

In healthy neurons, [MCL-1](/proteins/mcl1-protein) is a critical survival factor that sequesters BAK at the mitochondrial outer membrane, preventing spontaneous MOMP. MCL-1 also has non-apoptotic functions in mitochondrial metabolism and dynamics. NOXA binding to MCL-1 targets the complex for proteasomal degradation via the E3 ubiquitin ligase MULE/HUWE1, simultaneously eliminating both the survival signal and NOXA itself.[@mojsa2014] This mutual destruction mechanism ensures that NOXA functions as a one-shot trigger: once expressed above a threshold level, it irreversibly commits the cell to MCL-1 degradation and BAK/BAX activation.

Role in Neurodegenerative Disease

Alzheimer's Disease

NOXA is upregulated in vulnerable brain regions in [Alzheimer's disease](/diseases/alzheimers-disease):

[Amyloid-beta](/proteins/amyloid-beta) toxicity — oligomeric amyloid-beta peptides (Abeta-42) activate p53 in hippocampal neurons, leading to NOXA induction and MCL-1 depletion. Genetic deletion of Pmaip1 (Noxa) in mice reduces Abeta-induced neuronal apoptosis in hippocampal slice cultures.[@bhatt2007]
ER stress — amyloid-beta accumulation in the endoplasmic reticulum activates the UPR-ATF4-NOXA axis, contributing to apoptosis in cortical neurons[@wang2009]
Cell cycle re-entry — aberrant CDK4/E2F1 activation in AD neurons induces NOXA as part of the apoptotic cascade triggered by inappropriate S-phase entry in post-mitotic cells

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease) models, NOXA contributes to dopaminergic neuron loss:

6-OHDA and MPP+ models — both toxins induce p53-dependent NOXA expression in dopaminergic neurons of the substantia nigra. NOXA knockdown by siRNA partially protects against 6-OHDA toxicity in vitro[@bernstein2011]
Proteasome inhibition — proteasomal dysfunction (a feature of Lewy body pathology) stabilizes NOXA by preventing its normal ubiquitin-dependent turnover, lowering the apoptotic threshold[@seo2009]
[Alpha-synuclein](/proteins/alpha-synuclein) aggregation — alpha-synuclein oligomers impair proteasome function and activate ER stress, both of which converge on NOXA upregulation

Cerebral Ischemia and Stroke

NOXA is one of the most rapidly and strongly induced BH3-only proteins following cerebral ischemia-reperfusion. In rodent middle cerebral artery occlusion (MCAO) models, NOXA mRNA increases 5–10-fold within hours of reperfusion in the penumbral zone. Noxa-knockout mice show reduced infarct volumes and improved neurological outcomes after transient focal ischemia.[@kim2004]

Excitotoxicity

Glutamate excitotoxicity — a common pathogenic mechanism across neurodegenerative diseases — triggers NOXA through calcium-dependent p53 activation. [NMDA receptor](/entities/nmda-receptor) overstimulation in cortical neurons induces NOXA within 2–4 hours, preceding cytochrome c release and caspase-3 activation.[@bhatt2007]

Therapeutic Implications

MCL-1 Stabilization

Because NOXA kills neurons primarily by eliminating MCL-1, strategies to stabilize MCL-1 may protect against NOXA-mediated apoptosis. GSK-3beta inhibitors stabilize MCL-1 by preventing its phosphorylation-dependent ubiquitination, and lithium (a GSK-3 inhibitor) has shown neuroprotective effects in AD and stroke models.[@mojsa2014]

p53 Pathway Modulation

Pifithrin-alpha, a p53 transcriptional activity inhibitor, reduces NOXA expression and protects hippocampal neurons from Abeta toxicity in vitro. However, systemic p53 inhibition carries oncogenic risk, limiting translational potential.[@bhatt2007]

BH3 Mimetics — Context-Dependent Effects

BH3 mimetic drugs (e.g., venetoclax/ABT-199) are designed to mimic BH3-only proteins and kill cancer cells. In neurodegeneration, the goal is the opposite: to block endogenous BH3-only proteins like NOXA. Selective NOXA-BH3 peptide antagonists or decoy MCL-1 constructs are being explored as neuroprotective tools.[@moldoveanu2014]

UPR Modulation

Targeting the ER stress-ATF4-NOXA axis with PERK inhibitors (e.g., GSK2606414) or integrated stress response inhibitor (ISRIB) may reduce NOXA induction during chronic ER stress in neurodegeneration.[@wang2009]

External Links

[UniProt: Q13794](https://www.uniprot.org/uniprot/Q13794)
[GeneCards: PMAIP1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PMAIP1)
[OMIM: 604959](https://www.omim.org/entry/604959)
[Human Protein Atlas: PMAIP1](https://www.proteinatlas.org/ENSG00000141682-PMAIP1)

References

[Oda et al., Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/10807576/)

[Chen et al., Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15735003/)

[Bhatt et al., Noxa mediates p53-dependent apoptosis in hippocampal neurons (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17267500/)

[Day et al., Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1 (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18267077/)

[Seo et al., The C-terminal tail of Noxa protein localizes to the mitochondria via the mitochondria outer membrane targeting tail-anchor sequence (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/18835387/)

[Kim et al., Noxa is critical for p53-dependent hypoxia-induced apoptosis (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/15210740/)

[Wang et al., ER stress-activated ATF4 induces Noxa to promote neuronal apoptosis (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/17551078/)

[Mojsa et al., Control of neuronal apoptosis by reciprocal regulation of NFkappaB and the ubiquitin proteasome system (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/21098232/)

[Bernstein et al., 6-OHDA-generated oxidative stress induces p53-dependent apoptosis in dopaminergic neurons (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/22427557/)

[Moldoveanu et al., Many players in BCL-2 family affairs (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24216760/)

📖 View canonical wiki page →

NOXA Protein

NOXA Protein

Overview

NOXA Protein

Overview

Structure and Biochemistry

Normal Function in the Nervous System

p53-Dependent DNA Damage Response

Cellular Stress Sentinel

MCL-1 Regulation and Apoptotic Threshold

Role in Neurodegenerative Disease

Alzheimer's Disease

Parkinson's Disease

Cerebral Ischemia and Stroke

Excitotoxicity

Therapeutic Implications

MCL-1 Stabilization

p53 Pathway Modulation

BH3 Mimetics — Context-Dependent Effects

UPR Modulation

See Also

External Links

References